Breakthrough Vaccine Shows Safety and Efficacy Against Lassa and Rabies in Human Trial
A first-in-human phase 1 trial published this week in Nature Medicine found an experimental vaccine combining inactivated rabies virus and Lassa fever antigens—with an adjuvant to boost immune response—to be ... Read More